SI-BONE INC (SIBN)
US8257041090 - Common Stock
SI-BONE To Present at Piper Sandler 36th Annual Healthcare Conference on December 4, 2024
SANTA CLARA, Calif., Nov. 20, 2024 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), a medical device company dedicated to solving sacropelvic disorders,...
Curious about the stocks that are showing activity after the closing bell on Tuesday?
Get insights into the top gainers and losers of Tuesday's after-hours session.
SI-BONE, Inc. Reports Financial Results for the Third Quarter 2024 and Updates Guidance
Expects to achieve positive Adjusted EBITDA in Fourth Quarter 2024...
SIBN Crosses Above Key Moving Average Level
SI-BONE Receives Transitional Pass-Through Payment Status for iFuse Bedrock Granite™
The iFuse Bedrock Granite™ system is a Breakthrough Device Designation technology that provides pelvic fixation and sacroiliac joint fusion, in conjunction...
SI-BONE To Report Third Quarter 2024 Financial Results on November 12, 2024
SANTA CLARA, Calif., Oct. 22, 2024 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), a medical device company dedicated to solving sacropelvic disorders,...
Noteworthy Friday Option Activity: AXP, SIBN, ITOS
SI-BONE, Inc. Announces First-In-Patient Procedures with FDA Breakthrough Device for Pelvic Fracture Fixation
SANTA CLARA, Calif., Oct. 10, 2024 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), a Silicon Valley-based medical device company dedicated to providing...
SIBN Makes Bullish Cross Above Critical Moving Average
SI-BONE To Present at Morgan Stanley 22nd Annual Global Healthcare Conference on September 4, 2024
SANTA CLARA, Calif., Aug. 22, 2024 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), a medical device company dedicated to solving sacropelvic disorders,...
SI-BONE, Inc. Receives 510(k) Clearance and FDA Breakthrough Device Designation for Pelvic Fracture Fixation System
SANTA CLARA, Calif., Aug. 20, 2024 (GLOBE NEWSWIRE) -- SI-BONE, Inc., (Nasdaq: SIBN), a Silicon Valley-based medical device company dedicated to...
Noteworthy Friday Option Activity: SIBN, COIN, FWRD
SI-BONE To Present at Canaccord Genuity 44th Annual Growth Conference on August 14, 2024
SANTA CLARA, Calif., Aug. 06, 2024 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), a medical device company dedicated to solving sacropelvic disorders,...
SIBN Stock Earnings: SI-BONE Beats EPS, Beats Revenue for Q2 2024
InvestorPlace - Stock Market News, Stock Advice & Trading Tips SI-BONE (NASDAQ:SIBN) just reported results for the second quarter of 2024.SI-B...
SIBN Stock Earnings: SI-BONE Beats EPS, Beats Revenue for Q2 2024
SIBN stock results show that SI-BONE beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024.
SI-BONE, Inc. Reports Financial Results for the Second Quarter 2024
Increases 2024 revenue guidance to $165 million - $167 millionExpects to achieve positive Adjusted EBITDA in Fourth Quarter 2024 SANTA CLARA, Calif., Aug....
7 Leading MedTech Stocks for Next-Gen Health Solutions
With healthcare innovations promising to deliver groundbreaking solutions, these MedTech stocks should be on your radar.
Noteworthy Friday Option Activity: CVNA, SIBN, B
SIBN Makes Bullish Cross Above Critical Moving Average
SI-BONE To Report Second Quarter 2024 Financial Results on August 5, 2024
SANTA CLARA, Calif., July 15, 2024 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), a medical device company dedicated to solving musculoskeletal...
SI-BONE To Present at Truist Securities 2024 MedTech Conference on June 18, 2024
SANTA CLARA, Calif., June 05, 2024 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), a medical device company dedicated to solving musculoskeletal...
Noteworthy Friday Option Activity: SIBN, ZM, RCUS
SI-BONE Expands Portfolio with the Launch of New Offering for the iFuse Bedrock Granite Implant System and Completes Inaugural Surgical Procedures
SANTA CLARA, Calif., May 07, 2024 (GLOBE NEWSWIRE) -- SI-BONE, Inc., (Nasdaq: SIBN), a Silicon Valley-based medical device company dedicated to solving...
SIBN Stock Earnings: SI-BONE Beats EPS, Beats Revenue for Q1 2024
SIBN stock results show that SI-BONE beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.
SI-BONE, Inc. Reports Financial Results for the First Quarter 2024
Annual guidance increased to $164 million - $166 million, implying annual growth of ~18% - 20%...
SI-BONE To Present at BofA Securities 2024 Healthcare Conference on May 14, 2024
SANTA CLARA, Calif., April 29, 2024 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), a medical device company dedicated to solving musculoskeletal...
Notable Friday Option Activity: COIN, SIBN, DYN
SI-BONE To Report First Quarter 2024 Financial Results on May 6, 2024
SANTA CLARA, Calif., April 15, 2024 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), a medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy today announced it will report financial results for the first quarter of 2024 after market close on Monday, May 6, 2024. Management will host a corresponding conference call beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time.
SI-BONE Enters Oversold Territory (SIBN)
SI-BONE to Present at Barclays 26th Annual Global Healthcare Conference on March 12, 2024
SANTA CLARA, Calif., March 04, 2024 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), a medical device company dedicated to solving musculoskeletal...